First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.45 USD
Updated: May 15, 2024

Interpace Biosciences Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Interpace Biosciences Inc
Income from Continuing Operations Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Interpace Biosciences Inc
OTC:IDXG
Income from Continuing Operations
$1.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Income from Continuing Operations
$1.1B
CAGR 3-Years
2%
CAGR 5-Years
9%
CAGR 10-Years
2%
Quest Diagnostics Inc
NYSE:DGX
Income from Continuing Operations
$870m
CAGR 3-Years
-22%
CAGR 5-Years
4%
CAGR 10-Years
0%
CVS Health Corp
NYSE:CVS
Income from Continuing Operations
$7.4B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
4%
Cigna Corp
NYSE:CI
Income from Continuing Operations
$3.9B
CAGR 3-Years
-23%
CAGR 5-Years
4%
CAGR 10-Years
7%
Laboratory Corporation of America Holdings
NYSE:LH
Income from Continuing Operations
$400.3m
CAGR 3-Years
-47%
CAGR 5-Years
-15%
CAGR 10-Years
-3%

See Also

What is Interpace Biosciences Inc's Income from Continuing Operations?
Income from Continuing Operations
1.1m USD

Based on the financial report for Dec 31, 2023, Interpace Biosciences Inc's Income from Continuing Operations amounts to 1.1m USD.